Browsing Vanderbilt Law Review by Subject "health law, Food and Drug Administration, Risk Evaluation and Mitigation"
Now showing items 1-1 of 1
-
(Vanderbilt Law Review, 2024-04)When health is at stake, bureaucratic delays can be disastrous. This is especially true in the field of pharmaceutical regulation. Fortunately, concerned parties—ranging from research institutions and universities to doctors ...